Global Pharmatech, Inc. Stock

Stocks

GBLP

US37945N1090

OTC Markets Traded
Market Closed - 15:59:56 2026-06-05 EDT 5-day change 1st Jan Change
0.0801 USD +60.18% Intraday chart for Global Pharmatech, Inc. +0.01% +60.20%
1 week+0.01%
Current month+0.01%

Valuation: Global Pharmatech, Inc.

Market Cap 4.72M 4.2M 3.93M 3.56M 6.71M 455M 6.77M 47.2M 18.32M 232M 17.73M 17.35M 747M P/E 2006
-20.5x
P/E 2007 -4.23x
Enterprise Value 2.04M 1.81M 1.7M 1.54M 2.9M 197M 2.93M 20.4M 7.92M 100M 7.66M 7.5M 323M EV / Sales 2006
11.5x
EV / Sales 2007 4.95x
Free-Float
-
Yield 2006 *
-
Yield 2007 -
1 day+60.18%
1 week+0.01%
Current month+0.01%
1 month+0.01%
3 months+0.01%
6 months+60.20%
Current year+60.20%
Current year 0.05
Extreme 0.05
0.08
1 year 0.05
Extreme 0.05
0.08
3 years 0.05
Extreme 0.05
0.35
5 years 0.05
Extreme 0.05
0.6
10 years 0.01
Extreme 0.008
0.9
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Director/Board Member - -

Financials

2006 2007
Net sales 2.38M 2.11M 1.98M 1.79M 3.38M 229M 3.4M 23.74M 9.21M 117M 8.92M 8.72M 376M 2.82M 2.5M 2.35M 2.12M 4.01M 272M 4.04M 28.17M 10.93M 139M 10.58M 10.35M 446M
Net income -1.23M -1.1M -1.03M -930K -1.75M -119M -1.77M -12.34M -4.79M -60.71M -4.63M -4.53M -195M -3.3M -2.93M -2.74M -2.49M -4.69M -318M -4.73M -32.97M -12.79M -162M -12.38M -12.12M -522M
Net Debt -2.68 -2.38 -2.23 -2.02 -3.81 -258.1 -3.84 -26.77 -10.39 -131.73 -10.05 -9.84 -423.7 -2.68 -2.38 -2.23 -2.02 -3.81 -258.36 -3.84 -26.8 -10.4 -131.86 -10.06 -9.85 -424.13
Logo Global Pharmatech, Inc.
Global Pharmatech Inc is a company primarily engaged in the research, production and development of herbal medicine, bio-medicine, chemical medicine, traditional Chinese medicine (TCM) and dietary supplements. The Company’s main patented products include JUTAI SOFT CAPSULE, QINGXUAN ANTI-HYPERTENSION TABLET, YANREQING TABLET. The Company is also engaged in the manufacture and sales of other proprietary drugs, generics and dietary supplements used to treat symptoms ranging from headaches, coughing and dry mouth to infections and numbness of limbs. The Company also engages in the provision of biotechnology services, including research and development, testing, manufacturing drugs in liquid and solid dose forms, sales and marketing. The Company conducts its business in the domestic and overseas markets.
Employees
-
Sector
-
  1. Stock Market
  2. Stocks
  3. GBLP Stock